Literature DB >> 10636386

An alternative view of homocysteine.

N P Dudman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10636386     DOI： 10.1016/S0140-6736(99)03383-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Effect of physical exercise on thiols in the plasma in the athletic horse: connection with the immune system.

Authors:  L Avellini; E Chiaradia; L Terracina; A Gaiti
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.

Authors:  R Marcucci; D Brogi; F Sofi; C Giglioli; S Valente; A Alessandrello Liotta; M Lenti; A M Gori; D Prisco; R Abbate; G F Gensini
Journal:  Heart       Date:  2005-07-01       Impact factor: 5.994

Review 3.  Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties.

Authors:  Federico Cacciapuoti
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

4.  Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.

Authors:  M A Hofmann; E Lalla; Y Lu; M R Gleason; B M Wolf; N Tanji; L J Ferran; B Kohl; V Rao; W Kisiel; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 5.  Homocysteine levels in patients with stroke: clinical relevance and therapeutic implications.

Authors:  G J Hankey; J W Eikelboom
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function.

Authors:  K R Davis; H Pearson; S Moat; J R Bonham; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

7.  Circulating blood markers and functional impairment in peripheral arterial disease.

Authors:  Mary M McDermott; Kiang Liu; Luigi Ferrucci; Lu Tian; Jack M Guralnik; David Green; Jin Tan; Yihua Liao; William H Pearce; Joseph R Schneider; Kimberly McCue; Paul Ridker; Nader Rifai; Michael H Criqui
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

8.  Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes).

Authors:  Elaine N Videan; Christopher B Heward; Kajal Chowdhury; John Plummer; Yali Su; Richard G Cutler
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

Review 9.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

10.  Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke.

Authors:  Giuseppe Salemi; M C Gueli; M D'Amelio; V Saia; P Mangiapane; P Aridon; P Ragonese; I Lupo
Journal:  Neurol Sci       Date:  2009-05-30       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.